Johnson & Johnson announced that the FDA has approved Edurant Ped (rilpivirine) for the treatment of HIV-1 in combination with other antiretroviral therapies (ARVs) in treatment-naïve children (with… read more.
AstraZeneca and Sanofi’s Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in Japan for the prophylaxis of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus… read more.
Sobi announced positive results from the AVA-PED-301 study (NCT04516967), evaluating the efficacy and safety of avatrombopag (Doptelet) for the treatment of paediatric patients with immune thrombocytopenia (ITP) of… read more.
New research from the University of Pittsburgh and UPMC shows that telemedicine visits conducted for children with primary care providers (PCPs) are associated with fewer antibiotic prescriptions than telemedicine visits with virtual-only… read more.
Exposure to several combinations of toxic atmospheric pollutants may be triggering asthma symptoms among children, a recent analysis suggests. The study, published in the journal Science of the Total… read more.
A new study suggests that delta-8-THC, an intoxicating substance typically made from hemp, is being used by a substantial number of young people across the United States and could potentially pose… read more.
The nationwide baby formula shortage two years ago forced many parents to involuntarily switch brands or types. A recent survey from researchers at the University of California, Davis,… read more.
Children prenatally exposed to anesthesia for maternal surgery during pregnancy were significantly more likely than unexposed children to receive a diagnosis of a disruptive or internalizing behavioral disorder… read more.
Ben-Gurion University of the Negev and Soroka University Medical Center researchers have found that tonsillectomy in children with obstructive sleep apnea does not increase the risk of obesity… read more.
The increased popularity of telehealth and telemedicine in recent years has provided a new level of accessibility for patients to visit doctors and learn more about their health…. read more.
Vertex Pharmaceuticals announced that the European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the label expansion of Kalydeco (ivacaftor)… read more.
Antidepressant dispensing to adolescents and young adults increased sharply after the COVID-19 pandemic began – particularly among females – a new study finds. While a growing number of… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
